|
|
||||||||||||||
|
|
||||||||||||||
|
In 1991, Labodia opened a branch in Moscow in order to serve large hospital labs in Russia but this business segment was closed in 2006. In 1993, Labodia started its own production of ELISA kits in the autoimmunity field. After a rough starting period, we started building a sound reputation as a manufacturer of affordable, easy-to-use, quality reagents. In 1996, Labodia started the production of confirmatory tests (Western blots) for Lyme disease in close cooperation with Swiss opinion leaders in this field. In 2002, Labodia expanded its product range in the field of autoimmunity under the registered brand name Orkit with new ELISA kits. In 2005, the Lyme product line has been transferred to NovaTec Immundiagnostica while current R&D efforts are focused on autoimmunity. In 2006, a new ELISA kit for the diagnostic of autoimmune hepatitis with the detection of anti-LKM1 antibodies was developped. In July 2006 Labodia opened a subsidiary in France.
|
||||||||||||||
Last version: 29.07.08